Anticancer Research: 44 (1)

January 2024; Volume 44,Issue 1

Review

Open Access
Proteinase-activated Receptor 2: Springboard of Tumors
DAVID VETVICKA, PETR SUHAJ, TOMAS OLEJAR, LADISLAV SIVAK, JIRI BENES and PAVLA POUCKOVA

Anticancer Research January 2024, 44 (1) 1-12; DOI: https://doi.org/10.21873/anticanres.16782

Experimental Studies

Open Access
Brain Metastases Are Regulated by Immuno-inflammatory Signaling Pathways Governed by STAT3, MAPK and Tumor Suppressor p53 Status: Possible Therapeutic Targets
SABRINA L. ZELLER, ERIS SPIROLLARI, ALIS J. DICPINIGAITIS, JOHN V. WAINWRIGHT, SIMON J. HANFT, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL

Anticancer Research January 2024, 44 (1) 13-22; DOI: https://doi.org/10.21873/anticanres.16783
Open Access
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model
TSUBASA GOSHIMA, KATSUAKI IEGUCHI, NOBUYUKI ONISHI, TAKASHI SHIMIZU, DAISUKE TAKAYANAGI, MAKOTO WATANABE, YUKI FUJIMOTO, RYOTARO OHKUMA, RISAKO SUZUKI, TOSHIAKI TSURUI, EMIKO MURA, NANA IRIGUCHI, TOMOYUKI ISHIGURO, MASAHIRO SHIMOKAWA, YUYA HIRASAWA, YUTARO KUBOTA, HIROTSUGU ARIIZUMI, ATSUSHI HORIIKE, KIYOSHI YOSHIMURA, MAYUMI TSUJI, YUJI KIUCHI, SHINICHI KOBAYASHI, JUN FUJISHIRO, ROBERT M. HOFFMAN, TAKUYA TSUNODA and SATOSHI WADA

Anticancer Research January 2024, 44 (1) 23-29; DOI: https://doi.org/10.21873/anticanres.16784
Open Access
Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer
MOTOKAZU SATO, QINGHONG HAN, YUTARO KUBOTA, ANTON BARANOV, DANIEL ARDJMAND, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, MICHAEL BOUVET, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research January 2024, 44 (1) 31-35; DOI: https://doi.org/10.21873/anticanres.16785
Open Access
Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy
AYAKA OZAKI, AKARI MATSUDA, YUKI MAEMURA, YUNA TADA, TAKAHIRO KASAI, YUKA NAGASHIMA, CHOTARO ONAGA, YASUSHI HARA, KAZUKI KITABATAKE, MITSUTOSHI TSUKIMOTO, SHOMA TAMORI, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO

Anticancer Research January 2024, 44 (1) 37-47; DOI: https://doi.org/10.21873/anticanres.16786
You have access
Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia
SHOHEI MIYATA, TAKASHI ISHII and SUSUMU KITANAKA

Anticancer Research January 2024, 44 (1) 49-59; DOI: https://doi.org/10.21873/anticanres.16787
Open Access
Doublet and Triplet Combinations of Eribulin, Fulvestrant, and Palbociclib in Preclinical Breast Cancer Models
ISMAHENE BENZAID, MARC HILLAIRET DE BOISFERON, ELODIE MARIE DIT CHATEL and BRUCE A. LITTLEFIELD

Anticancer Research January 2024, 44 (1) 61-70; DOI: https://doi.org/10.21873/anticanres.16788
You have access
Peptide L13S Derived from the BRN2 POU Domain Reduces Metastasis In Vivo and Inhibits Cell Migration and Invasion In Vitro
MARIA CAROLINA MARIANO CESAR, RENATO ARRUDA MORTARA, VICTÓRIA SANTOS SOUZA, VITORIA RODRIGUES GUIMARAES ALVES, THAYSA PASCHOALIN, MARCO ANTONIO SOUFEN, GUILHERME MENDES DE FREITAS, FERNANDA FERNANDES MIRANDA DA CUNHA, DAYANE BATISTA TADA, ANDREY SENOS DOBROFF and DENISE COSTA ARRUDA

Anticancer Research January 2024, 44 (1) 71-84; DOI: https://doi.org/10.21873/anticanres.16789
You have access
Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells
CHUN-YI LI, HSIN-CHUAN CHEN, CHIH-YING LIAO, FEI-TING HSU, KUANG-CHEN HUNG, KUO-CHING LIU, JAW-CHYUN CHEN and MING-CHOU KU

Anticancer Research January 2024, 44 (1) 85-92; DOI: https://doi.org/10.21873/anticanres.16790
You have access
Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression
DAISUKE OKA, YOSHITAKA SEKINE, YUSUKE TSUJI, HIROSHI NAKAYAMA, YOSHIYUKI MIYAZAWA, SEIJI ARAI, HIDEKAZU KOIKE and KAZUHIRO SUZUKI

Anticancer Research January 2024, 44 (1) 93-98; DOI: https://doi.org/10.21873/anticanres.16791
You have access
Synergistic VSV Virotherapy and Carbon Nanotube Photothermal Therapy for Osteosarcoma in Murine Models
TOMOHIKO SAKUDA, AKIHIRO ODA, TAISUKE FURUTA, MUHAMMAD PHETRUS JOHAN, TAKEMASA SAKAGUCHI and NOBUO ADACHI

Anticancer Research January 2024, 44 (1) 99-105; DOI: https://doi.org/10.21873/anticanres.16792
You have access
SNPs as Stochastic Oscillators in Inheritance of Human Diseases
ANTHOULA CHATZIKYRIAKIDOU

Anticancer Research January 2024, 44 (1) 107-115; DOI: https://doi.org/10.21873/anticanres.16793
You have access
Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer
MIN JIANG, YONG LIU, JIANZHONG XU, ZHEN XU, TAO YE, SHIYANG LI and CHUNYING JIANG

Anticancer Research January 2024, 44 (1) 117-131; DOI: https://doi.org/10.21873/anticanres.16794

Clinical Studies

Open Access
Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial
MOLLY K. TATE, MIKE HERNANDEZ, JOE Y. CHANG, STEVEN H. LIN, ZHONGXING LIAO, SUJA M. KOSHY, HEATH D. SKINNER and STEPHEN G. CHUN

Anticancer Research January 2024, 44 (1) 133-137; DOI: https://doi.org/10.21873/anticanres.16795
Open Access
Safer and More Convenient Modern Curative Radiotherapy for Patients With Early Prostate Cancer
PETRI REINIKAINEN, ILARI LEHTINEN, TIINA LUUKKAALA and PIRKKO-LIISA KELLOKUMPU-LEHTINEN

Anticancer Research January 2024, 44 (1) 139-150; DOI: https://doi.org/10.21873/anticanres.16796
Open Access
Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center
MADISON NICHOLS, ANAM KESARIA, HORACE J. SPENCER, HEATHER R. WILLIAMS, SANTANU SAMANTA and GARY D. LEWIS

Anticancer Research January 2024, 44 (1) 151-155; DOI: https://doi.org/10.21873/anticanres.16797
Open Access
Evaluation of Intraoperative Neural Monitoring During Thoracoscopic Surgery for Esophageal Cancer
SHIGERU LEE, YUSHI FUJIWARA, KEN GYOBU, TATSURO TAMURA, TAKAHIRO TOYOKAWA, YUICHIRO MIKI, MAMI YOSHII, HIROAKI KASASHIIMA, TATSUNARI FUKUOKA, MASATSUNE SHIBUTANI, HARUSHI OSUGI and KIYOSHI MAEDA

Anticancer Research January 2024, 44 (1) 157-166; DOI: https://doi.org/10.21873/anticanres.16798
You have access
A Standardized Interrupted Parachute Suture Technique in Hepaticojejunostomy for Patients With Perihilar Cholangiocarcinoma
NAOKAZU CHIBA, YUTA ABE, AKITOSHI ANDO, MASASHI NAKAGAWA, SHIGETO OCHIAI, TAKAHIRO GUNJI, TORU SANO, KOICHI TOMITA and SHIGEYUKI KAWACHI

Anticancer Research January 2024, 44 (1) 167-171; DOI: https://doi.org/10.21873/anticanres.16799
You have access
The Diagnostic Accuracy (DA) of ColonView Fecal Immunochemical Test (FIT) in Detecting Colorectal Adenoma (CRA) Can Be Improved by the Diagnostic Models (DM) that Include Triage and Risk Features of CRA
MAARET ESKELINEN, JANNICA MEKLIN, DENISE PEIXOTO GUIMARAES, TUOMAS SELANDER, KARI SYRJÄNEN and MATTI ESKELINEN

Anticancer Research January 2024, 44 (1) 173-184; DOI: https://doi.org/10.21873/anticanres.16800
You have access
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma
TAKAHITO SUGASE, TAKASHI KANEMURA, TOMOHIRA TAKEOKA, NORIHIRO MATSUURA, YASUNORI MASUIKE, NAOKI SHINNO, HISASHI HARA, MASATOSHI KITAKAZE, MASAHIKO KUBO, YOSUKE MUKAI, TOSHINORI SUEDA, SHINICHIRO HASEGAWA, HIROFUMI AKITA, JUNICHI NISHIMURA, HIROSHI WADA, MASAYOSHI YASUI, TAKESHI OMORI and HIROSHI MIYATA

Anticancer Research January 2024, 44 (1) 185-193; DOI: https://doi.org/10.21873/anticanres.16801
Open Access
Long-term Results of a Phase II Study of Neoadjuvant SOX for Advanced Gastric Cancer
SHUNICHI ITO, HIDEKAZU KURAMOCHI, AKIKO SERIZAWA, MASAHO OTA, SATOSHI KATAGIRI, SHINSUKE MAEDA and KEI HOSODA

Anticancer Research January 2024, 44 (1) 195-204; DOI: https://doi.org/10.21873/anticanres.16802
You have access
Survival Benefit of Stereotactic Radiotherapy in the Complex Management of Metastatic Melanoma
GYÖNGYI KELEMEN, ZSÓFIA EGYÜD, ÁGNES DOBI, LINDA VARGA, RENÁTA KÓSZÓ, EMŐKE BORZÁSI, VIKTOR PACZONA, ZOLTÁN VÉGVÁRY, FERENC BORZÁK, EMESE FODOR, HENRIETTA ÓCSAI, ESZTER BALTÁS, JUDIT OLÁH and KATALIN HIDEGHÉTY

Anticancer Research January 2024, 44 (1) 205-212; DOI: https://doi.org/10.21873/anticanres.16803
You have access
Efficacy of Sunitinib in Patients With Favorable and Intermediate Risk Metastatic Renal Cell Carcinoma – Lithuanian National Cancer Institute Experience
ALGIRDAS ZALIMAS, VINCAS URBONAS, DAIVA DABKEVICIENE, JONAS PURVANECKAS, ALBERTAS ULYS and SONATA JARMALAITE

Anticancer Research January 2024, 44 (1) 213-219; DOI: https://doi.org/10.21873/anticanres.16804
You have access
Clinical Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgical Patients With Pancreatic Cancer
SHINNOSUKE KAWAHARA, TORU AOYAMA, MASAAKI MURAKAWA, REI KANEMOTO, DAISHI TAKAHASHI, YUTO KAMIOKA, ITARU HASHIMOTO, MARIKO KAMIYA, AYA KATO, YUKIO MAEZAWA, KEISUKE KAZAMA, SHO SAWAZAKI, HIROSHI TAMAGAWA, SATOSHI KOBAYASHI, MAKOTO UENO, NAOTO YAMAMOTO, TAKASHI OSHIMA, NORIO YUKAWA, YASUSHI RINO, AYA SAITO and SOICHIRO MORINAGA

Anticancer Research January 2024, 44 (1) 221-228; DOI: https://doi.org/10.21873/anticanres.16805
You have access
Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
TAKASHI NAKANISHI, TAKERU MATSUDA, KIMIHIRO YAMASHITA, HIROSHI HASEGAWA, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, SHINGO KANAJI, TARO OSHIKIRI and YOSHIHIRO KAKEJI

Anticancer Research January 2024, 44 (1) 229-237; DOI: https://doi.org/10.21873/anticanres.16806
You have access
Incidence Trends of Melanoma of the Lower Limbs and Hips in the United States: A Surveillance, Epidemiology, and End Results Analysis 2000-2019
SOLANGE N. WALZ, JEROME MARTINEAU, MATTEO SCAMPA, SRINIVAS MADDURI, DANIEL F. KALBERMATTEN and CARLO M. ORANGES

Anticancer Research January 2024, 44 (1) 239-247; DOI: https://doi.org/10.21873/anticanres.16807
You have access
Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment
TORU AOYAMA, AYA KATO, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, SHINNOSUKE KAWAHARA, KEISUKE KAZAMA, KEISUKE KOMORI, SUZUE YOSHIZAWA, AYAKO TAMAGAWA, MINORI TATEISHI, TOMOYUKI MINAMI, HARUHIKO CHO, JUNYA MORITA, KAZUKI OTANI, SHO SAWAZAKI, MASAKATAU NUMATA, MIE TANABE, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO

Anticancer Research January 2024, 44 (1) 249-255; DOI: https://doi.org/10.21873/anticanres.16808
You have access
Time on Treatment and Survival Outcomes for Patients Treated With First-line Osimertinib vs. Other Tyrosine Kinase Inhibitors, for EGFR Mutation-positive Metastatic Non-small Cell Lung Cancer: Real-world Experience Data
SARAH SHARMAN MOSER, LIOR APTER, JOSIE SOLOMON, GABRIEL CHODICK, MIRIANA WOLLNER and NAVA SIEGELMANN-DANIELI

Anticancer Research January 2024, 44 (1) 257-265; DOI: https://doi.org/10.21873/anticanres.16809
You have access
Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer
JOSEFINE BAUDREXL, SEBASTIAN PIETZKA, MARIO SCHEURER, ALEXANDER SCHRAMM, FRANK WILDE, ANDREAS SAKKAS, SPYRIDOULA DERKA and MARCEL EBELING

Anticancer Research January 2024, 44 (1) 267-286; DOI: https://doi.org/10.21873/anticanres.16810
You have access
Catalase Expression Is an Independent Prognostic Marker in Lung Adenocarcinoma
PO-MING CHEN, YU-HAN HUANG, HSIN-HUNG CHEN and PEI-YI CHU

Anticancer Research January 2024, 44 (1) 287-300; DOI: https://doi.org/10.21873/anticanres.16811
You have access
Sex Differences in Presentation, Treatment, and Survival in Patients Receiving Palliative (Chemo)Radiotherapy for Non-Small Cell Lung Cancer
CARSTEN NIEDER, SIV GYDA AANES, ASTRID DALHAUG and ELLINOR CHRISTIN HAUKLAND

Anticancer Research January 2024, 44 (1) 301-305; DOI: https://doi.org/10.21873/anticanres.16812
You have access
Clinical Significance of Chitinase-3-like Protein 1 Gene Expression in Patients With Locally Advanced Gastric Cancer
TAKASHI OSHIMA, ITARU HASHIMOTO, YUKIHIKO HIROSHIMA, YAYOI KIMURA, MIE TANABE, SHIZUNE ONUMA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO and YOHEI MIYAGI

Anticancer Research January 2024, 44 (1) 307-312; DOI: https://doi.org/10.21873/anticanres.16813
You have access
Ibuprofen Reduces 5-Year Overall Survival of Head and Neck Cancer Patients With Immunotherapy – A Retrospective Case-controlled Real-World Data Analysis of 10,000 Patients
MARCEL EBELING, SPYRIDOULA DERKA, JOSEFINE BAUDREXL, ANDREAS SAKKAS, MARIO SCHEURER, FRANK WILDE, ALEXANDER SCHRAMM and SEBASTIAN PIETZKA

Anticancer Research January 2024, 44 (1) 313-322; DOI: https://doi.org/10.21873/anticanres.16814
You have access
Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB–VMAT
NAHOMI YOSHIMURA, MASAYUKI FUJIWARA, MASATAKA IGETA, HITOMI SUZUKI, RYO KUNIMOTO, TOMONORI TERADA, YUICHIRO SHINODA, MASATAKA NAKAMURA, JUNKO FUKUTAKE, HARUYUKI TAKAKI and KOICHIRO YAMAKADO

Anticancer Research January 2024, 44 (1) 323-329; DOI: https://doi.org/10.21873/anticanres.16815
You have access
Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
AYA KATO, TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, KENTARO HARA, KEISUKE KAZAMA, MASAKATSU NUMATA, SHO SAWAZAKI, AYAKO TAMAGAWA, HARUHIKO CHO, JUNYA MORITA, MIE TANABE, NATSUMI KAMIYA, HIROSHI TAMAGAWA, KAZUKI OTANI, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, NORIO YUKAWA, AYA SAITO and YASUSHI RINO

Anticancer Research January 2024, 44 (1) 331-337; DOI: https://doi.org/10.21873/anticanres.16816
You have access
Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment
TORU AOYAMA, AYA KATO, YUKIO MAEZAWA, ITARU HASHIMOTO, KENTARO HARA, KEISUKE KOMORI, SHINNOSUKE KAWAHARA, MASAKATSU NUMATA, KEISUKE KAZAMA, SHO SAWAZAKI, NATSUMI KAMIYA, SUZUE YOSHIZAWA, KAZUKI OTANI, AYAKO TAMAGAWA, HARUHIKO CHO, HIROSHI TAMAGAWA, TAKASHI OSHIMA, NORIO YUKAWA, AYA SAITO and YASUSHI RINO

Anticancer Research January 2024, 44 (1) 339-346; DOI: https://doi.org/10.21873/anticanres.16817
You have access
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study
JWA HOON KIM, YONGJUN CHA, SANG JOON SHIN, YOUNG SUK PARK, JUNG HUN KANG, CHAN KIM, SUNG HEE LIM, MYOUNG JOO KANG, JONG GWANG KIM, IN GYU HWANG, JONG-KWON CHOI, SEONG HOON SHIN, SEOK YUN KANG, SANG-CHEOL LEE, SEUNG TAEK LIM, JUNG SUN KIM, HEI-CHEUL JEUNG, MYOUNG HEE KANG, IN SIL CHOI, HYE WON RYU, KYUNG HEE LEE, MOON HEE LEE, JI YOUNG LEE, JI HYUN PARK, SO-YEON JEON, NAMSU LEE, CHI-YOUNG PARK and YEUL HONG KIM

Anticancer Research January 2024, 44 (1) 347-359; DOI: https://doi.org/10.21873/anticanres.16818
You have access
Efficacy of Adding Locoregional Therapy in Non-Complete Remission Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Preliminary Study
TORU ISHIKAWA, SHUN YAMAZAKI, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA

Anticancer Research January 2024, 44 (1) 361-368; DOI: https://doi.org/10.21873/anticanres.16819
You have access
Clinical Significance of Pregnancy Zone Protein Expression in Patients With Locally Advanced Gastric Cancer After Curative Resection
TAKASHI OSHIMA, ITARU HASHIMOTO, YUKIHIKO HIROSHIMA, YAYOI KIMURA, MIE TANABE, SHIZUNE ONUMA, JUNYA MORITA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO and YOHEI MIYAGI

Anticancer Research January 2024, 44 (1) 369-374; DOI: https://doi.org/10.21873/anticanres.16820
You have access
Medium-term Outcomes of Excision Using Surgical Microscope of Tenosynovial Giant Cell Tumors of the Hand
YUTA NAKAMURA, KAORU TADA, MIKA AKAHANE, SOICHIRO HONDA, SHO HORIE, KAZUO IKEDA and HIROYUKI TSUCHIYA

Anticancer Research January 2024, 44 (1) 375-378; DOI: https://doi.org/10.21873/anticanres.16821
You have access
Discontinuation of Immune-oncology Combinations due to Immune-related Adverse Events in Patients With Advanced Renal Cancers
KENSUKE BEKKU, MANUELA SCHMIDINGER, SATOSHI KATAYAMA, TATSUSHI KAWADA, TAKAFUMI YANAGISAWA, TAKEHIRO IWATA, KOHEI EDAMURA, TOMOKO KOBAYASHI, YASUYUKI KOBAYASHI, MOTOO ARAKI and SHAHROKH F. SHARIAT

Anticancer Research January 2024, 44 (1) 379-386; DOI: https://doi.org/10.21873/anticanres.16822
You have access
Evaluation of Quality of Life and Prognosis of Gastric Cancer Patients After Laparoscopic Subtotal Gastrectomy
MASATAKA SHIMONOSONO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, YUSUKE TSURUDA, KEN SASAKI, KENJI BABA, YASUTO UCHIKADO, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research January 2024, 44 (1) 387-396; DOI: https://doi.org/10.21873/anticanres.16823
You have access
Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced Gastric Cancer After Curative Resection
TAKASHI OSHIMA, ITARU HASHIMOTO, YUKIHIKO HIROSHIMA, YAYOI KIMURA, MIE TANABE, SHIZUNE ONUMA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO and YOHEI MIYAGI

Anticancer Research January 2024, 44 (1) 397-402; DOI: https://doi.org/10.21873/anticanres.16824
You have access
Increasing Patients With HPV-positive Oropharyngeal Squamous Cell Carcinoma and its Oncologic Outcomes in the Rural Region in Northern Japan
KODAI TSUCHIDA, KIYOTO SHIGA, KATSUNORI KATAGIRI, DAISUKE SAITO, SHIN-ICHI OIKAWA, AYA IKEDA, JUN MIYAGUCHI, TAKAHIRO KUSAKA, IORI KUSAKA, YU OHASHI and HISANORI ARIGA

Anticancer Research January 2024, 44 (1) 403-407; DOI: https://doi.org/10.21873/anticanres.16825
You have access
Dietary Intake After Surgery in Patients With Gastric Cancer Who Underwent Laparoscopic-assisted Versus Those Who Underwent Conventional Gastrectomy
JUNYA MORITA, TORU AOYAMA, MASATO NAKAZONO, MIE TANABE, SHIZUNE ONUMA, SHINNOSUKE KAWAHARA, ITARU HASHIMOTO, KEISUKE KOMORI, KENTARO HARA, KYOHEI KANEMATSU, SHINSUKE NAGASAWA, YUKIO MAEZAWA, TAKANOBU YAMADA, TAKASHI OGATA, HARUHIKO CHO, NORIO YUKAWA, YASUSHI RINO, AYA SAITO and TAKASHI OSHIMA

Anticancer Research January 2024, 44 (1) 409-415; DOI: https://doi.org/10.21873/anticanres.16826
You have access
Role of Radical Surgery Following Preoperative Chemoradiotherapy in Octogenarians With Rectal Cancer: A SEER Analysis
YU JIN LIM and MOONKYOO KONG

Anticancer Research January 2024, 44 (1) 417-425; DOI: https://doi.org/10.21873/anticanres.16827
Open Access
Association of Pre-operative Geriatric Nutritional Risk Index With Complete Adjuvant Chemotherapy and Prognosis Post-pancreatectomy
TOSHIYA HIGASHI, KATSUTOSHI MURASE, RYOMA YOKOI, MASASHI KUNO, MASAHIRO FUKADA, JESSE YU TAJIMA, SHIGERU KIYAMA, YOSHIHIRO TANAKA, NAOKI OKUMURA and NOBUHISA MATSUHASHI

Anticancer Research January 2024, 44 (1) 427-434; DOI: https://doi.org/10.21873/anticanres.16828
You have access
Surgical Bedside Electrochemotherapy for Local Control of a Recurrent Phylloid Malignant Breast Tumor: A Case Report
GIACOMO CORRADO, SONIA BOVE, BENEDETTA ALBERGHETTI, SIMONA MARIA FRAGOMENI, LUCA TAGLIAFERRI, GIOVANNI SCAMBIA and GIORGIA GARGANESE

Anticancer Research January 2024, 44 (1) 435-439; DOI: https://doi.org/10.21873/anticanres.16829

Book Reviews

Open Access
Book Reviews
Anticancer Research January 2024, 44 (1) 441-442; DOI: https://doi.org/10.21873/anticanres.16830

Corrigendum

Open Access
Corrigendum
Anticancer Research January 2024, 44 (1) 443; DOI: https://doi.org/10.21873/anticanres.16831

Main menu

User menu

Search

Table of Contents

Review

Experimental Studies

Clinical Studies

Book Reviews

Corrigendum

In this issue

Issue highlights

Jump to